Insertion of prosthetic devices such as catheters and joint replacements into patients provides pathogenic microorganisms with a substratum on which they can form adherent biofilms consisting of layers of cells embedded in a matrix material (2, 3, (7) (8) (9) (10) . Bacterial biofilms of this type, including those produced by Staphylococcus epidermidis and Pseudomonas aeruginosa, are relatively insensitive to antibiotic treatment (1, 3) , and eradication of implant-associated infections often involves removal of the infected prosthesis. Investigations into the mechanisms of antibiotic resistance suggest that the recalcitrance of biofilm cells may be due to reduced drug penetration into biofilms, nutrient limitation, a low bacterial growth rate, or the production of antibiotic-degrading enzymes (1) .
The majority of implant infections attributable to fungi are caused by the pathogenic Candida species, especially Candida albicans. Recently, we described a model system for studying Candida biofilms growing on the surface of small discs of catheter material (11) . Biofilm growth was monitored quantitatively by dry weight, colorimetric, and radioisotope assays and was visualized by scanning electron microscopy. In the present study, we have used the model system to determine the susceptibility of Candida biofilms to five clinically important antifungal agents.
C. albicans GDH 2346, a denture stomatitis isolate (13) , was used in most of these experiments. Other C. albicans strains and Candida species were from a collection described previously (11) . MICs of antifungal agents for C. albicans GDH 2346 were determined, courtesy of F. C. Odds, at the Janssen Research Foundation, Beerse, Belgium, by a microplate modification of the National Committee for Clinical Laboratory Standards protocol (14) with broths containing 2% glucose in RPMI 1640 medium. For biofilm studies, the organism was grown in yeast nitrogen base medium (Difco) containing 50 mM glucose or 500 mM galactose for 24 h as reported elsewhere (11, 13) , and washed cell suspensions were adjusted to an optical density of 0.8 at 520 nm. Biofilms were formed on small discs (surface area, 0.5 cm 2 ) cut from polyvinyl chloride central venous catheters (Rüsch UK Ltd., High Wycombe, United Kingdom) and sterilized with ethylene oxide as described previously (11) . Briefly, the discs were placed in wells of 24-well Nunclon tissue culture plates, and a standardized cell suspension (80 l) was applied to the surface of each one. Initially, incubation lasted 1 h at 37ЊC (adhesion period). Nonadherent organisms were removed by washing, and the discs were then incubated in the wells for 48 h at 37ЊC, submerged in 1 ml of growth medium (biofilm formation).
Amphotericin B (Sigma), flucytosine (5-fluorocytosine; Sigma), fluconazole (Pfizer), itraconazole (Janssen), and ketoconazole (Janssen) were all tested against 48-h biofilms in the model system. Stock solutions of the drugs in dimethyl sulfoxide (amphotericin B, itraconazole, and ketoconazole), sterile distilled water (flucytosine), and dimethylformamide (fluconazole) were prepared immediately prior to use and diluted in growth medium buffered to pH 7 with 0.165 M morpholinepropanesulfonic acid (MOPS) buffer (Sigma). Following incubation of catheter discs for 48 h at 37ЊC, the growth medium was removed from each well and replaced with 1 ml of buffered medium containing the test antifungal agent at concentrations ranging from 0 to 250 g/ml. The biofilms were incubated for a further 5 h at 37ЊC and then washed gently in 5 ml of 0.15 M phosphate-buffered saline (PBS), pH 7.2. Biofilm activity was assessed by [ All of the antifungal agents tested showed much less activity against 48-h biofilms than against planktonic cells (Table 1 ). IL 50 s and IF 50 s for biofilms were 5 to 8 times higher than the corresponding values for planktonic cells and 30 to 2,000 times higher than the relevant MICs. Results for biofilms grown in medium containing 50 mM glucose as the carbon source were very similar to those for biofilms grown in medium with 500 mM galactose. Fluconazole was the most effective agent against biofilms, with IL 50 s and IF 50 s five and three times lower, respectively, than those for amphotericin B, the least effective agent (Table 1) . When combinations of drugs were used, the greatest synergism was observed with amphotericin B and flucytosine. Interestingly, although the lowest MICs were obtained for itraconazole and ketoconazole (Յ0.025 g/ml), the activities of these azoles against biofilms were similar to that of amphotericin B (Table 1 ). An analogous lack of correlation between MICs and the effectiveness of different cephalosporins for Escherichia coli biofilms was reported by Dix et al. (5) . These investigators originally devised the [ In a separate series of experiments, biofilm inocula (used for the initial adhesion phase of biofilm development) were exposed to antifungal agents prior to biofilm formation. Drugs were added to yeast suspensions (80 l of suspension in 900 l of buffered growth medium) at final concentrations ranging from 0 to 100 g/ml. After incubation for 1 h at 37ЊC, suspensions were centrifuged at 2,500 ϫ g for 5 min and the cells were washed twice with 1 ml of 0.15 M PBS, pH 7.2, to remove antifungal agents. Cell suspensions were then applied to the surface of catheter discs in wells of tissue culture plates and incubated for 1 h at 37ЊC (adhesion period). Nonadherent organisms were removed by washing, and the discs were incubated for a further 48 h at 37ЊC in 1 ml of growth medium without drugs (biofilm formation). The effects of antifungal agents were determined by the [ 3 H]leucine incorporation and tetrazolium reduction assays as before and expressed as drug concentrations that caused a 50% inhibition of biofilm or planktonic cell activity (IL 50 or IF 50 ) following preincubation with inocula.
This treatment of inocula resulted in IL 50 s and IF 50 s for biofilms ( Table 2 ) that were significantly lower (often by a factor of 2) than those recorded for treated, 48-h biofilms (Table 1) ; however, they were still substantially higher than the corresponding values for planktonic cells or the relevant MICs. With the drug combinations tested, differences in IL 50 s and IF 50 s for biofilms were much smaller. As before, fluconazole was the most effective agent against biofilms, and amphotericin B was the least effective agent (Table 2 ). IL 50 s and IF 50 s for flucytosine, itraconazole, and ketoconazole were reasonably similar and indicated that these compounds are typically three to four times less effective than fluconazole at inhibiting biofilm development when added to inocula under the conditions of this experiment. The activities of all of the antifungal agents were again largely unaffected by the nature of the carbon source (glucose or galactose) used.
The effect of amphotericin B on 48-h biofilms was also investigated by scanning electron microscopy using procedures described previously (11) . Biofilms treated with the drug at a concentration of 15 g/ml (11 times the MIC) for 5 h were quite similar in appearance to untreated (control) biofilms, consisting of a dense mixture of yeasts, pseudohyphae, and a The data are means for three independent experiments carried out in triplicate. Cells were grown in medium containing 50 mM glucose (Glc) or 500 mM galactose (Gal). ND, not determined.
b The concentrations of the two drugs were equal. a The data are means for three independent experiments carried out in triplicate. Cells were grown in medium containing 50 mM glucose (Glc) or 500 mM galactose (Gal). ND, not determined.
b The concentrations of the two drugs were equal.
VOL. 39, 1995 NOTES 2129 hyphae ( Fig. 1A and B) ; several of the cells appeared swollen, but the overall structure of the biofilm remained intact. Treatment with amphotericin B at 50 g/ml (38 times the MIC), which approximates the IL 50 s and IF 50 s for this drug (Table 1) , caused a large reduction in cell numbers and in the thickness of the biofilm (Fig. 1C ). An even higher drug concentration, 100 g/ml (77 times the MIC), produced large amounts of cell debris, and relatively few intact cells remained (Fig. 1D) . Overall, our results indicate that biofilms of C. albicans, like those of bacteria, are highly resistant to antimicrobial agents.
Although the data presented in Tables 1 and 2 were obtained with a single strain of the organism, we have tested a total of 13 different isolates of C. albicans. All gave similar results; for example, experiments with fluconazole produced IL 50 s and IF 50 s for biofilms ranging from 9.6 to 14.4 and from 9.9 to 17.6 g/ml, respectively (Table 3) (Table 3) . A variety of mechanisms have been proposed to explain the recalcitrance of bacterial biofilms to antibiotics, including exclusion of the drug by the biofilm matrix (1) . The mechanisms by which Candida biofilms resist the action of antifungal agents are unknown. When C. albicans biofilms are formed under conditions of static incubation, as described here, very little matrix material is evident. However, we have recently found that gentle shaking to produce a flow of liquid over the catheter disc significantly increases the synthesis of matrix material by biofilm cells so that, in some cases, the cells are completely enveloped (12) . Such conditions probably resemble those present in vivo more closely than does static incubation and may increase fungal resistance still further. Additional studies are required to investigate this possibility, perhaps with a flow system of the type described by Domingue et al. (6) , which incorporates National Committee for Clinical Laboratory Standards guidelines into the testing of biofilm bacteria for sensitivity to antibiotics.
